0000874015-20-000084.txt : 20200629
0000874015-20-000084.hdr.sgml : 20200629
20200629214759
ACCESSION NUMBER: 0000874015-20-000084
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200625
FILED AS OF DATE: 20200629
DATE AS OF CHANGE: 20200629
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Castleman Breaux
CENTRAL INDEX KEY: 0001335073
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19125
FILM NUMBER: 201000134
MAIL ADDRESS:
STREET 1: 7 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000874015
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330336973
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
BUSINESS PHONE: 7609319200
MAIL ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
FORMER COMPANY:
FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2020-06-25
0
0000874015
IONIS PHARMACEUTICALS INC
IONS
0001335073
Castleman Breaux
C/O IONIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT
CARLSBAD
CA
92010
1
0
0
0
Common Stock
2020-06-25
4
M
0
10000
26.66
A
25183
D
Common Stock
2020-06-25
4
S
0
10000
60
D
15183
D
Director Stock Option (right to buy)
26.66
2020-06-25
4
M
0
10000
0
D
2017-06-25
2023-06-24
Common Stock
10000
12500
D
Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on March 5, 2020.
Patrick O'Neil, Attorney-in-Fact
2020-06-29